Top

Journal of Neuro-Oncology

Published in:

01-12-2018 | Letter to the Editor

The importance of adequate methotrexate and adequate folinic acid rescue doses in the treatment of primary brain lymphoma

Author: Ian J. Cohen

Published in: Journal of Neuro-Oncology | Issue 3/2018

Excerpt

To the Editor, …

Adhikari N, Biswas A, Gogia A et al (2018) A prospective phase II trial of response adapted radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome. J Neurooncol 139:153–166CrossRefPubMed

Cohen IJ, Vogel R, Matz S et al (1986) Successful non-toxic therapy without radiation) of a multifocal primary brain lymphoma with a methotrexate vincristine and BCNU protocol (DEMOB). Cancer 57:6–11CrossRefPubMed

Shkalim VS, Toledano H, Ash S et al (2016) Factors affecting the upper limit of the methotrexate (MTX) CSF levels achievable in children with brain tumors reated with high- dose intravenous MTX. J Pediatr Hematol Oncol 38:544–548CrossRef

Cohen IJ (2013) Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate(HDMTX). Med Hypotheses 81:942–947CrossRefPubMed

Title: The importance of adequate methotrexate and adequate folinic acid rescue doses in the treatment of primary brain lymphoma
Author: Ian J. Cohen
Publication date: 01-12-2018
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2018
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-018-2999-x

ACC 2024 Congress

Springer Medicine

The importance of adequate methotrexate and adequate folinic acid rescue doses in the treatment of primary brain lymphoma

Excerpt

ACC 2024 Congress

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2018

Social cognition in patients with intracranial tumors: do we forget something in the routine neuropsychological examination?

Gamma knife radiosurgery for recurrent gliomas

Possible effects of radiofrequency electromagnetic fields on in vivo C6 brain tumors in Wistar rats

Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer

Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience

Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the “head-start” I and II clinical trials